Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke.
A trial of subcutaneous low-dose heparin in the prevention of deep-vein thrombosis was carried out in elderly patients admitted to hospital after an acute stroke. A statistically significant reduction was observed in deep-vein thrombosis as assessed by isotope leg scanning.
D000208:Acute Disease; D000368:Aged; D002561:Cerebrovascular Disorders / Q000150:complications*; D005260:Female; D005340:Fibrinogen; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D007457:Iodine Radioisotopes; D007553:Isotope Labeling; D007866:Leg / Q000098:blood supply; D008297:Male; D011877:Radionuclide Imaging; D013924:Thrombophlebitis / Q000453:epidemiology / Q000517:prevention & control*
D007457:Iodine Radioisotopes; D005340:Fibrinogen; D006493:Heparin